Medable Platform Delivers >90% eCOA Adherence And Scalability

A leading American pharmaceutical company, ranked among the top ten in the industry, approached Medable with an ambitious project. They sought to undertake an extensive weight management master protocol clinical trial, which included multiple sub-studies spread across more than 70 research sites.

The primary concern for the client was the participant experience. The trial's design necessitated that participants first enroll through the master protocol before they could join any of the sub-studies. This layered enrollment process raised worries about potential complexities and burdens on the participants.

Additionally, the client expressed a desire for a solution that could be reused and scaled for future trials. They emphasized the importance of maintaining a seamless and positive experience for both the research sites and the participants, ensuring that efficiency and ease of use would not be compromised in the pursuit of scalability and reusability.